5-甲氧基-2-[(4-甲氧基苯基)甲基]苯酚 | 433331-88-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 5-甲氧基-2-[(4-甲氧基苯基)甲基]苯酚
• 英文名称: 5-methoxy-2-(4-methoxybenzyl)phenol
• 英文别名: 5-methoxy-2-[(4-methoxyphenyl)methyl]phenol
• CAS: 433331-88-5
• 化学式: C₁₅H₁₆O₃
• 分子量: 244.29
• InChiKey: WAXQLKGYUGFJTL-UHFFFAOYSA-N

物化性质

• 沸点：
  399.0±32.0 °C(Predicted)
• 密度：
  1.134±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  38.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-甲氧基-2-[(4-甲氧基苯基)甲基]苯酚 生成 5-methoxy-2-(4-methoxybenzyl)phenyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside
  参考文献：
  名称：

  EP1344780

  摘要：

  公开号：
• 作为产物：
  描述：

  (2-羟基-4-甲氧基苯基)-(4-甲氧基苯基)甲酮 在 三乙胺 、 氯甲酸甲酯 、 sodium tetrahydroborate 作用下， 以 四氢呋喃 为溶剂， 以76%的产率得到5-甲氧基-2-[(4-甲氧基苯基)甲基]苯酚
  参考文献：
  名称：

  A New Series of Estrogen Receptor Modulators: Effect of Alkyl Substituents on Receptor-Binding Affinity

  摘要：

  新型选择性雌激素受体调节剂（SERMs）被合成并评估其与生殖细胞的结合亲和力和生物学效应。提议的先导结构（B）被衍生化以提供化合物30和44，这些化合物显示出良好的雌激素受体结合亲和力（Ki值：分别为6.3和10 nM），同时对乳腺癌和子宫癌细胞的影响较小。核心结构中引入烷基基团显著增强了测试化合物的受体结合亲和力。文中描述了这些化合物的合成及其结构–活性关系。

  DOI：

  10.1248/cpb.52.79

文献信息

• Synthetically Useful Brønsted Acid-Promoted Arylbenzyl Ether → <i>o</i>-Benzylphenol Rearrangements
  作者：Frederick A. Luzzio、Juan Chen

  DOI：10.1021/jo9007833

  日期：2009.8.7

  Camphorsulfonic acid in warm fluorobenzene facilitates the ortho rearrangement of (alkoxy-substituted) benzyl ethers of 1-(O-methyl)-2-nitroresorcinols to the corresponding o-(alkoxy-substituted) arylmethylnitrophenols. The substrate phenolic ethers are prepared by ultrasound-promoted arylmethylation of the appropriate 1-alkoxy-substituted 2-nitroresorcinol.

  温暖的氟苯中的樟脑磺酸促进了1-（O-甲基）-2-硝基间苯二酚的（烷氧基取代的）苄基醚的邻位重排为相应的o-（烷氧基取代的）芳基甲基硝基苯酚。通过超声促进合适的1-烷氧基取代的2-硝基间苯二酚的芳基甲基化来制备底物酚醚。
• Experimental and Computational Studies on the Ruthenium-Catalyzed Dehydrative C–H Coupling of Phenols with Aldehydes for the Synthesis of 2-Alkylphenol, Benzofuran, and Xanthene Derivatives
  作者：Nuwan Pannilawithana、Bimal Pudasaini、Mu-Hyun Baik、Chae S. Yi

  DOI：10.1021/jacs.1c06887

  日期：2021.8.25

  with benzaldehyde and 2-propanol/2-propanol-d8 (kH/kD = 2.3 ± 0.3). The carbon isotope effect was observed on the benzylic carbon of the alkylation product from the coupling reaction of 3-methoxyphenol with 4-methoxybenzaldehyde (C(3) 1.021(3)) and on both benzylic and ortho-arene carbons from the coupling reaction with 4-trifluorobenzaldehdye (C(2) 1.017(3), C(3) 1.011(2)). The Hammett plot from the

  阳离子Ru-H配合物[(C 6 H 6 )(PCy 3 )(CO)RuH] + BF 4 - ( 1 )被发现是酚类和醛类脱水C-H偶联反应生成的有效催化剂2-烷基苯酚产品。酚类与支链醛的偶联反应选择性地形成1,1-二取代苯并呋喃，而与水杨醛的偶联反应产生呫吨衍生物。从 3-甲氧基苯酚与苯甲醛和 2-丙醇/2-丙醇-d 8 ( k H / k D ) 的偶联反应中观察到正常的氘同位素效应= 2.3 ± 0.3)。在 3-甲氧基苯酚与 4-甲氧基苯甲醛 (C(3) 1.021(3)) 偶联反应的烷基化产物的苄基碳以及与4-三氟苯甲醛 (C(2) 1.017(3)、C(3) 1.011(2))。来自 3-甲氧基苯酚与对位取代苯甲醛p -XC 6 H 4 CHO (X = OMe, Me, H, F, Cl, CF 3 ) 的偶联反应的 Hammett 图显示了 V 形线性斜率。通过 NMR 从1
• Selective Estrogen Receptor Modulator
  申请人：Hamaoka Shinichi

  公开号：US20120004315A1

  公开（公告）日：2012-01-05

  The present invention provides a compound represented by the following formula (I); [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof.

  本发明提供一种由以下式（I）表示的化合物; [其中T表示单键，可能具有取代基的C1-C4烷基和类似物；式（I-1）表示单键或双键；A表示单键，可能具有取代基的双价5-至14-成员杂环基和类似物；Y表示单键和类似物；Z表示亚甲基基团和类似物；环G表示苯基团和类似物，可能与5-至6-成员环缩合并可能具有杂原子；Ra和Rb相同或不同，表示氢原子和类似物；W表示单键和类似物；R'表示1到4个独立的氢原子和类似物；R''表示1到4个独立的氢原子和类似物]或其盐或水合物。
• Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
  申请人：Fujikura Hideki

  公开号：US20050113315A1

  公开（公告）日：2005-05-26

  The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein R 1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group etc.; R 2 represents a hydrogen atom or a lower alkyl group; and R 3 represents a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group, a substituted or unsubstituted(lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.

  本发明涉及一种由通式表示的葡萄糖吡喃氧基苯基苯乙烯衍生物： 其中，R1表示氢原子，羟基，取代或未取代的氨基，氨基甲酰基，取代或未取代的（较低烷基）基团，取代或未取代的（较低烷氧基）基团等；R2表示氢原子或较低烷基基团；R3表示取代或未取代的（较低烷基）基团，取代或未取代的（较低烷氧基）基团，取代或未取代的（较低烷硫基）基团等，或其药学上可接受的盐，其具有对人类SGLT2的抑制活性，可用作预防或治疗与高血糖相关的疾病，如糖尿病、糖尿病并发症或肥胖症的药物，以及包含它们的制药组合物和中间体。
• Selective estrogen receptor modulator
  申请人：Hamaoka Shinichi

  公开号：US20060116364A1

  公开（公告）日：2006-06-01

  The present invention provides a compound represented by the following formula [wherein T represents a single bond, a C1-C4 alkylene group which may have a substituent and the like; formula (I-1) represents a single bond or a double bond; A represents a single bond, a bivalent 5- to 14-membered heterocyclic group which may have a substituent and the like; Y represents a single bond and the like; Z represents a methylene group and the like; ring G represents a phenylene group and the like which may condense with a 5- to 6-membered ring and may have a heteroatom; R a and R b are the same as or different from each other and represent a hydrogen atom and the like; W represents a single bond and the like; R′ represents 1 to 4 independent hydrogen atoms and the like; and R″ represents 1 to 4 independent hydrogen atoms and the like] or a salt thereof, or a hydrate thereof

  本发明提供了一种化合物，其表示为以下式子[其中T表示单键，C1-C4的烷基，可能带有取代基等；式(I-1)表示单键或双键；A表示单键，二价的5-至14-成员杂环基团，可能带有取代基等；Y表示单键等；Z表示亚甲基等；环G表示苯基团等，可与5-至6-成员环缩合并且可能具有杂原子；Ra和Rb相同或不同，表示氢原子等；W表示单键等；R'表示1至4个独立的氢原子等；R"表示1至4个独立的氢原子等]或其盐，或其水合物。